Cash flow PIOLAX, Inc.

Stocks

5988

JP3780400002

Auto, Truck & Motorcycle Parts

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-07-31 EDT			5-day change	1st Jan Change
1,743.00 ^JPY	-.--%		+4.81%	+0.64%

07-03	Tranche Update on PIOLAX, Inc.'s Equity Buyback Plan announced on February 12, 2026.	CI
05-12	PIOLAX, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026	CI

2a5.ovh0AlrCjVqQbxcOHm79CJX8DZc3KYGA8h0i_JZaFc8.kpMiV2OJySvIBmVgKl66TvetP81oW_XMhm0SkM88WIzSn0ZPMoy-COApVg

Published financial data: PIOLAX, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	55.14B	58.42B	64.55B	63.35B	62.04B
Total Revenues	55.14B	58.42B	64.55B	63.35B	62.04B
Cost of Goods Sold, Total	40.07B	43.73B	48.29B	49.08B	48.32B
Gross Profit	15.08B	14.69B	16.26B	14.27B	13.73B
Selling General & Admin Expenses, Total	9.41B	10.15B	10.74B	11.14B	11.18B
Provision for Bad Debts	-	13M	5M	3M	62M
Depreciation & Amortization - (IS)	451M	575M	757M	741M	984M
Other Operating Expenses	-	-	-	-	31M
Other Operating Expenses, Total	9.86B	10.74B	11.51B	11.89B	12.26B
Operating Income	5.22B	3.95B	4.76B	2.38B	1.47B
Interest Expense, Total	-8M	-19M	-13M	-14M	-254M
Interest And Investment Income	181M	336M	711M	741M	562M
Net Interest Expenses	173M	317M	698M	727M	308M
Income (Loss) On Equity Invest.	769M	688M	557M	316M	5M
Currency Exchange Gains (Loss)	-137M	-297M	-311M	-195M	-137M
Other Non Operating Income (Expenses)	-127M	254M	-140M	181M	-125M
EBT, Excl. Unusual Items	5.9B	4.91B	5.56B	3.41B	1.52B
Gain (Loss) On Sale Of Investments	-	5M	109M	3M	14M
Gain (Loss) On Sale Of Assets	-70M	-50M	-21M	-15M	-21M
Asset Writedown	-232M	-111M	-67M	-	-426M
Other Unusual Items	-	-	-	-	-326M
EBT, Incl. Unusual Items	5.59B	4.76B	5.58B	3.4B	763M
Income Tax Expense	1.3B	1.28B	1.5B	1.55B	769M
Earnings From Continuing Operations	4.29B	3.47B	4.09B	1.85B	-6M
Net Income to Company	4.29B	3.47B	4.09B	1.85B	-6M
Minority Interest	-68M	-96M	-74M	-60M	-15M
Net Income - (IS)	4.22B	3.38B	4.01B	1.79B	-21M
Net Income to Common Incl Extra Items	4.22B	3.38B	4.01B	1.79B	-21M
Net Income to Common Excl. Extra Items	4.22B	3.38B	4.01B	1.79B	-21M
Per Share Items
Net EPS - Basic	121.7	99.14	117.88	52.65	-0.82
Basic EPS - Continuing Operations	121.7	99.14	117.88	52.65	-0.82
Basic Weighted Average Shares Outstanding	34.71M	34.04M	34.04M	34.03M	25.5M
Net EPS - Diluted	121.7	99.14	117.88	52.65	-0.82
Diluted EPS - Continuing Operations	121.7	99.14	117.88	52.65	-0.82
Diluted Weighted Average Shares Outstanding	34.71M	34.04M	34.04M	34.03M	25.5M
Normalized Basic EPS	104.21	87.36	99.92	60.91	36.72
Normalized Diluted EPS	104.21	87.36	99.92	60.91	36.72
Dividend Per Share	45	100	118	92	92
Payout Ratio	40.7	68.53	111.04	193.75	-13.3K
Supplemental Items
EBITDA	8.51B	7.54B	8.63B	6.74B	5.91B
EBITA	5.22B	3.95B	4.76B	2.38B	1.47B
EBIT	5.22B	3.95B	4.76B	2.38B	1.47B
Effective Tax Rate - (Ratio)	23.27	27.02	26.78	45.55	100.79
Normalized Net Income	3.62B	2.97B	3.4B	2.07B	936M
Non-Cash Pension Expense	33M	86M	116M	123M	153M
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.06B	1.99B	2.02B	2.12B	2.06B
Research And Development Expense From Footnotes	661M	804M	810M	687M	744M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	35.5B	36.97B	35.65B	34.88B	26.19B
Short Term Investments	2.54B	1.86B	1.62B	796M	152M
Total Cash And Short Term Investments	38.04B	38.84B	37.27B	35.68B	26.34B
Accounts Receivable, Total	13.72B	15.15B	15.62B	14.24B	14.64B
Other Receivables	88M	322M	34M	205M	244M
Total Receivables	13.81B	15.47B	15.65B	14.44B	14.88B
Inventory	10.26B	10.79B	11.37B	11.46B	12.63B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	2.03B	1.81B	2.77B	2.82B	4.29B
Total Current Assets	64.14B	66.91B	67.06B	64.4B	58.14B
Net Property Plant And Equipment	23.74B	25.51B	30.16B	33.57B	35.84B
Long-term Investments	19.69B	21.08B	22.22B	5.47B	5.46B
Goodwill	-	-	-	-	-
Other Intangibles, Total	1.7B	1.61B	1.56B	1.56B	1.46B
Deferred Tax Assets Long-Term	409M	354M	404M	457M	516M
Other Long-Term Assets, Total	2M	2M	1M	1M	1M
Total Assets	110B	115B	121B	105B	101B
Liabilities
Accounts Payable, Total	2.68B	2.76B	3.15B	2.94B	3.15B
Accrued Expenses, Total	917M	936M	938M	813M	821M
Short-term Borrowings	-	-	-	-	24.17B
Current Portion of Leases	262M	115M	200M	179M	181M
Current Income Taxes Payable	359M	282M	689M	370M	279M
Other Current Liabilities	4.6B	4.19B	4.46B	7.91B	4.94B
Total Current Liabilities	8.82B	8.28B	9.44B	12.22B	33.54B
Long-Term Leases	142M	162M	91M	435M	222M
Pension & Other Post Retirement Benefits	217M	269M	323M	385M	485M
Deferred Tax Liability Non Current	1.98B	2.28B	2.3B	440M	780M
Other Non Current Liabilities	187M	221M	1.32B	206M	244M
Total Liabilities	11.34B	11.21B	13.47B	13.68B	35.27B
Common Stock, Total	2.96B	2.96B	2.96B	2.96B	2.96B
Additional Paid In Capital	2.57B	2.57B	2.63B	2.57B	2.57B
Retained Earnings	93.22B	94.36B	94.07B	77.44B	74.62B
Treasury Stock	-4.68B	-4.67B	-4.73B	-5.4B	-29.38B
Comprehensive Income and Other	2.82B	7.45B	11.37B	12.88B	14.08B
Total Common Equity	96.89B	103B	106B	90.44B	64.85B
Minority Interest	1.44B	1.58B	1.65B	1.34B	1.29B
Total Equity	98.33B	104B	108B	91.78B	66.14B
Total Liabilities And Equity	110B	115B	121B	105B	101B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	35.25M	34.04M	35.33M	25.44M	24.11M
ECS Total Common Shares Outstanding	35.25M	34.04M	34.04M	34.23M	24.27M
Book Value / Share	2.75K	3.02K	3.12K	2.64K	2.67K
Tangible Book Value	95.19B	101B	105B	88.88B	63.4B
Tangible Book Value Per Share	2.7K	2.97K	3.08K	2.6K	2.61K
Total Debt	404M	277M	291M	614M	24.57B
Net Debt	-37.64B	-38.56B	-36.98B	-35.06B	-1.77B
Debt Equivalent of Unfunded Proj. Benefit Obligation	218M	257M	315M	376M	449M
Minority Interest, Total (Incl. Fin. Div)	1.44B	1.58B	1.65B	1.34B	1.29B
Inventories - Raw Materials, Total	2.86B	3.05B	3.15B	3.08B	3.29B
Inventories - Work In Process, Total	2.08B	2.19B	2.24B	2.33B	2.66B
Inventories - Finished Goods, Total	5.32B	5.55B	5.98B	6.05B	6.68B
Full Time Employees	2.85K	2.82K	2.88K	2.9K	2.78K
Accumulated Allowance for Doubtful Accounts (Supple)	34M	38M	38M	41M	103M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	5.59B	4.76B	5.58B	3.4B	763M
Depreciation & Amortization - CF	3.29B	3.59B	3.87B	4.35B	4.44B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	3.29B	3.59B	3.87B	4.35B	4.44B
(Gain) Loss From Sale Of Asset	202M	161M	88M	15M	385M
(Gain) Loss on Sale of Investments - (CF)	-	-5M	-109M	-3M	-15M
(Income) Loss On Equity Investments - (CF)	-769M	-688M	-557M	-316M	-5M
Other Operating Activities, Total	-1.77B	-1.21B	-742M	-1.69B	-1.07B
Change In Accounts Receivable	1.79B	-826M	-80M	2B	-314M
Change In Inventories	-1.88B	212M	-114M	355M	-945M
Change In Accounts Payable	-109M	-347M	206M	-255M	336M
Change in Other Net Operating Assets	87M	425M	220M	267M	-568M
Cash from Operations	6.44B	6.07B	8.36B	8.12B	3B
Capital Expenditure	-2.55B	-4.25B	-7.35B	-4.55B	-9.56B
Sale of Property, Plant, and Equipment	8M	155M	404M	218M	130M
Sale (Purchase) of Intangible assets	-138M	-108M	-184M	-208M	-372M
Investment in Marketable and Equity Securities, Total	-1.08B	-730M	-1.53B	7.89B	2.09B
Other Investing Activities, Total	-102M	-67M	90M	-7M	153M
Cash from Investing	-3.86B	-5B	-8.57B	3.34B	-7.56B
Short Term Debt Issued, Total	-	-	-	-	26.17B
Total Debt Issued	-	-	-	-	26.17B
Short Term Debt Repaid, Total	-1.5B	-	-	-	-2B
Total Debt Repaid	-1.5B	-	-	-	-2B
Issuance of Common Stock	-	7M	209M	77M	1M
Repurchase of Common Stock	-1.5B	-	-210M	-2.56B	-23.98B
Common Dividends Paid	-1.72B	-2.31B	-4.46B	-3.47B	-2.79B
Common & Preferred Stock Dividends Paid	-1.72B	-2.31B	-4.46B	-3.47B	-2.79B
Other Financing Activities, Total	33M	-137M	-238M	-509M	-536M
Cash from Financing	-4.69B	-2.44B	-4.7B	-6.47B	-3.14B
Foreign Exchange Rate Adjustments	870M	520M	584M	490M	232M
Miscellaneous Cash Flow Adjustments	-	-	1M	1M	1M
Net Change in Cash	-1.24B	-856M	-4.32B	5.49B	-7.46B
Supplemental Items
Cash Interest Paid	8M	19M	13M	14M	261M
Cash Income Tax Paid (Refund)	1.85B	1.25B	811M	1.81B	1.06B
Levered Free Cash Flow	2.09B	-683M	-1.34B	4.94B	-10.67B
Unlevered Free Cash Flow	2.09B	-671M	-1.33B	4.95B	-10.51B
Change In Net Working Capital	1.77B	2.37B	645M	-3.87B	5.93B
Net Debt Issued / Repaid	-1.5B	-	-	-	24.17B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	3.02	2.19	2.51	1.31	0.89
Return on Total Capital	3.36	2.43	2.79	1.49	1
Return On Equity %	4.47	3.43	3.85	1.85	-0.01
Return on Common Equity	4.46	3.38	3.84	1.82	-0.03
Margin Analysis
Gross Profit Margin %	27.34	25.15	25.19	22.53	22.13
SG&A Margin	17.06	17.38	16.64	17.59	18.02
EBITDA Margin %	15.43	12.9	13.37	10.63	9.52
EBITA Margin %	9.46	6.76	7.37	3.76	2.37
EBIT Margin %	9.46	6.76	7.37	3.76	2.37
Income From Continuing Operations Margin %	7.78	5.94	6.33	2.92	-0.01
Net Income Margin %	7.66	5.78	6.22	2.83	-0.03
Net Avail. For Common Margin %	7.66	5.78	6.22	2.83	-0.03
Normalized Net Income Margin	6.56	5.09	5.27	3.27	1.51
Levered Free Cash Flow Margin	3.79	-1.17	-2.08	7.8	-17.19
Unlevered Free Cash Flow Margin	3.8	-1.15	-2.07	7.82	-16.94
Asset Turnover
Asset Turnover	0.51	0.52	0.55	0.56	0.6
Fixed Assets Turnover	2.34	2.37	2.32	1.99	1.79
Receivables Turnover (Average Receivables)	3.89	4.05	4.2	4.24	4.3
Inventory Turnover (Average Inventory)	4.45	4.16	4.36	4.3	4.01
Short Term Liquidity
Current Ratio	7.27	8.08	7.1	5.27	1.73
Quick Ratio	5.88	6.56	5.61	4.1	1.23
Operating Cash Flow to Current Liabilities	0.73	0.73	0.89	0.66	0.09
Days Sales Outstanding (Average Receivables)	93.82	90.18	87.22	86.01	84.93
Days Outstanding Inventory (Average Inventory)	82.1	87.84	83.95	84.87	90.97
Average Days Payable Outstanding	24.41	22.42	22.12	22.62	22.48
Cash Conversion Cycle (Average Days)	151.51	155.61	149.06	148.25	153.43
Long Term Solvency
Total Debt/Equity	0.41	0.27	0.27	0.67	37.15
Total Debt / Total Capital	0.41	0.26	0.27	0.66	27.09
LT Debt/Equity	0.14	0.16	0.08	0.47	0.34
Long-Term Debt / Total Capital	0.14	0.15	0.08	0.47	0.24
Total Liabilities / Total Assets	10.34	9.71	11.1	12.98	34.78
EBIT / Interest Expense	652.25	207.89	365.92	170.29	5.79
EBITDA / Interest Expense	1.06K	396.63	663.69	481.21	23.26
(EBITDA - Capex) / Interest Expense	744.75	172.89	98.38	156.07	-14.4
Total Debt / EBITDA	0.05	0.04	0.03	0.09	4.16
Net Debt / EBITDA	-4.42	-5.12	-4.29	-5.2	-0.3
Total Debt / (EBITDA - Capex)	0.07	0.08	0.23	0.28	-6.72
Net Debt / (EBITDA - Capex)	-6.32	-11.74	-28.91	-16.05	0.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.95	5.94	10.49	-1.86	-2.06
Gross Profit, 1 Yr. Growth %	17.46	-2.56	10.69	-12.24	-3.8
EBITDA, 1 Yr. Growth %	12.2	-11.44	14.49	-21.92	-12.32
EBITA, 1 Yr. Growth %	29.83	-24.3	20.43	-49.88	-38.3
EBIT, 1 Yr. Growth %	29.83	-24.3	20.43	-49.88	-38.3
Earnings From Cont. Operations, 1 Yr. Growth %	6.87	-19.13	17.75	-54.69	-100.32
Net Income, 1 Yr. Growth %	6.61	-20.1	18.9	-55.35	-101.17
Normalized Net Income, 1 Yr. Growth %	10.09	-17.78	14.38	-39.05	-54.84
Diluted EPS Before Extra, 1 Yr. Growth %	7.24	-18.54	18.9	-55.33	-101.56
Accounts Receivable, 1 Yr. Growth %	-6.23	10.43	3.08	-8.83	2.8
Inventory, 1 Yr. Growth %	32.21	5.12	5.37	0.8	10.22
Net Property, Plant and Equip., 1 Yr. Growth %	1.78	7.49	18.23	11.29	6.74
Total Assets, 1 Yr. Growth %	3.42	5.27	5.16	-13.14	-3.84
Tangible Book Value, 1 Yr. Growth %	4.84	6.17	3.63	-15.13	-28.67
Common Equity, 1 Yr. Growth %	4.85	5.96	3.53	-14.91	-28.29
Cash From Operations, 1 Yr. Growth %	-12.28	-5.79	37.85	-2.88	-63.04
Capital Expenditures, 1 Yr. Growth %	0.87	66.64	72.88	-38.06	110.13
Levered Free Cash Flow, 1 Yr. Growth %	-51.34	-132.7	96.45	-468.27	-315.84
Unlevered Free Cash Flow, 1 Yr. Growth %	-51.32	-132.05	98.72	-471.17	-312.25
Dividend Per Share, 1 Yr. Growth %	28.57	122.22	18	-22.03	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-6.05	7.93	8.19	4.13	-1.96
Gross Profit, 2 Yr. CAGR %	-5.79	6.98	3.86	-1.44	-8.12
EBITDA, 2 Yr. CAGR %	-10.71	-0.32	0.7	-5.45	-17.26
EBITA, 2 Yr. CAGR %	-12.11	-0.86	-4.52	-22.31	-44.39
EBIT, 2 Yr. CAGR %	-12.11	-0.86	-4.52	-22.31	-44.39
Earnings From Cont. Operations, 2 Yr. CAGR %	-9.97	-7.03	-2.42	-26.95	-96.17
Net Income, 2 Yr. CAGR %	-10.14	-7.7	-2.53	-27.13	-92.77
Normalized Net Income, 2 Yr. CAGR %	-11.37	-4.86	-3.02	-16.51	-47.54
Diluted EPS Before Extra, 2 Yr. CAGR %	-9.11	-6.53	-1.58	-27.13	-91.64
Accounts Receivable, 2 Yr. CAGR %	-1.35	1.76	6.69	-3.06	-3.19
Inventory, 2 Yr. CAGR %	10.97	17.89	5.24	3.06	5.41
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.56	4.6	12.73	14.71	9
Total Assets, 2 Yr. CAGR %	3.82	4.34	5.22	-4.43	-8.61
Tangible Book Value, 2 Yr. CAGR %	3.86	5.51	4.89	-6.22	-22.2
Common Equity, 2 Yr. CAGR %	3.69	5.4	4.74	-6.14	-21.89
Cash From Operations, 2 Yr. CAGR %	-13.37	-9.1	13.96	15.71	-40.08
Capital Expenditures, 2 Yr. CAGR %	-19.09	29.65	69.73	3.48	14.08
Levered Free Cash Flow, 2 Yr. CAGR %	-25.69	-60.11	-19.85	168.98	181.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	-25.65	-60.5	-20.19	171.58	180.68
Dividend Per Share, 2 Yr. CAGR %	0	69.03	61.93	-4.08	-11.7
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.88	-2.21	8.78	4.73	2.03
Gross Profit, 3 Yr. CAGR %	-9.2	-4.73	8.2	-1.81	-2.23
EBITDA, 3 Yr. CAGR %	-13.65	-10.95	4.39	-7.49	-7.8
EBITA, 3 Yr. CAGR %	-17.56	-16.38	5.78	-22.98	-28.05
EBIT, 3 Yr. CAGR %	-17.56	-16.38	5.78	-22.98	-28.05
Earnings From Cont. Operations, 3 Yr. CAGR %	-16.94	-13.13	0.59	-24.43	-88
Net Income, 3 Yr. CAGR %	-17.13	-13.59	0.43	-24.86	-81.61
Normalized Net Income, 3 Yr. CAGR %	-17.37	-13.56	1.17	-16.93	-31.97
Diluted EPS Before Extra, 3 Yr. CAGR %	-16.25	-12.37	1.27	-24.37	-79.75
Accounts Receivable, 3 Yr. CAGR %	-3.2	2.43	2.2	1.25	-1.14
Inventory, 3 Yr. CAGR %	6.61	8.98	13.56	3.74	5.39
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.51	1.37	8.96	12.25	11.99
Total Assets, 3 Yr. CAGR %	2.4	4.3	4.61	-1.3	-4.23
Tangible Book Value, 3 Yr. CAGR %	2.9	4.62	4.88	-2.26	-14.4
Common Equity, 3 Yr. CAGR %	2.82	4.44	4.78	-2.27	-14.2
Cash From Operations, 3 Yr. CAGR %	-16.12	-10.92	4.44	8.05	-20.9
Capital Expenditures, 3 Yr. CAGR %	-20.05	2.94	42.7	21.29	31.04
Levered Free Cash Flow, 3 Yr. CAGR %	-25.75	-43.48	-32.13	33.24	149.95
Unlevered Free Cash Flow, 3 Yr. CAGR %	-25.69	-43.84	-32.32	33.22	150.16
Dividend Per Share, 3 Yr. CAGR %	0	30.5	49.95	26.92	-2.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.02	-2.96	-1.12	0.28	4.35
Gross Profit, 5 Yr. CAGR %	-5.55	-6.74	-4.19	-3.43	1.35
EBITDA, 5 Yr. CAGR %	-9.63	-11.83	-8.17	-8.79	-4.88
EBITA, 5 Yr. CAGR %	-12.86	-17.32	-12.57	-18.8	-18.21
EBIT, 5 Yr. CAGR %	-12.86	-17.32	-12.57	-18.8	-18.21
Earnings From Cont. Operations, 5 Yr. CAGR %	-11.94	-15.84	-11.41	-18.95	-72.78
Net Income, 5 Yr. CAGR %	-12	-16.12	-11.57	-19.29	-64.94
Normalized Net Income, 5 Yr. CAGR %	-12.5	-15.2	-11.9	-14.75	-22.2
Diluted EPS Before Extra, 5 Yr. CAGR %	-11.44	-15.26	-10.67	-18.6	-62.66
Accounts Receivable, 5 Yr. CAGR %	-2.75	-1.46	0.64	0.2	0.01
Inventory, 5 Yr. CAGR %	7.41	6.33	6.06	6.57	10.22
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.67	0.95	3.96	6.51	8.97
Total Assets, 5 Yr. CAGR %	3.43	3.01	3.52	0.72	-0.89
Tangible Book Value, 5 Yr. CAGR %	4.27	3.68	3.69	0.14	-6.93
Common Equity, 5 Yr. CAGR %	4.38	3.67	3.58	0.07	-6.84
Cash From Operations, 5 Yr. CAGR %	-9.38	-9.24	-5.18	-1.09	-16.38
Capital Expenditures, 5 Yr. CAGR %	-10.12	3.89	8.05	3.16	30.48
Levered Free Cash Flow, 5 Yr. CAGR %	-16.83	-32.13	-23.44	5.49	19.97
Unlevered Free Cash Flow, 5 Yr. CAGR %	-16.83	-32.38	-23.54	5.5	19.56
Dividend Per Share, 5 Yr. CAGR %	6.19	20.11	21.26	15.38	21.32